about
Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouseShort-term administration of growth hormone (GH) lowers blood pressure by activating eNOS/nitric oxide (NO)-pathway in male hypophysectomized (Hx) rats.Echocardiographic assessment of subclinical left ventricular eccentric hypertrophy in adult-onset GHD patients by geometric remodeling: an observational case-control study.Understanding and meeting the needs of those using growth hormone injection devicesPre-weaning growth hormone treatment reverses hypertension and endothelial dysfunction in adult male offspring of mothers undernourished during pregnancy.Advances in growth hormone therapy: a new registry tool.Mortality in adults with hypopituitarism: a systematic review and meta-analysis.Growth hormone and its disordersCardiovascular disease, hypertension, dyslipidaemia and obesity in patients with hypothalamic-pituitary disease.Myths and truths of growth hormone and testosterone therapy in heart failure.Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: A single-center prospective case-control study.Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study.Combined dietary and pharmacological weight management in obese hypopituitary patients.A rare case of adulthood-onset growth hormone deficiency presenting as sporadic, symptomatic hypoglycemia.Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
P2860
Q24613998-67F215FA-FFDD-47D6-9671-578A44BAE177Q24811861-6E933326-F1DC-4F32-89D1-DFD181B641A7Q33235036-F6AEA293-16F5-4DA0-B564-5E5EC7EA1368Q33260085-1851073D-0A6E-49C7-8915-0600F2B79AAFQ34545145-CD9402D6-B331-4AA7-8E3A-237191212B3EQ35980569-E607950F-CC98-4509-882F-2742D761E77AQ36183713-175029E6-143E-4F6D-BE8B-D0A5C303F850Q36362200-46FC66CC-75A0-407F-A6D4-504C090D36CEQ37008652-3D70BBC5-2EE0-4B2E-A5B6-824798EF981CQ37895679-E44BE11A-CE9F-4921-97EA-BBA8AF559BFAQ41980483-DAA1B89E-3490-445E-AEF4-F517819589E4Q43690992-F4BF172D-1E57-4810-B886-3208F5FECC62Q45188956-742D76F4-CDD1-41DF-9C3B-01E185F4E4CDQ45309850-6D2784AA-CBED-4949-8159-4A5D03BFD2CDQ51498823-7EC01A41-ADF8-447B-9D1A-E13BB7F2133E
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Growth hormone deficiency and vascular risk.
@ast
Growth hormone deficiency and vascular risk.
@en
Growth hormone deficiency and vascular risk.
@nl
type
label
Growth hormone deficiency and vascular risk.
@ast
Growth hormone deficiency and vascular risk.
@en
Growth hormone deficiency and vascular risk.
@nl
prefLabel
Growth hormone deficiency and vascular risk.
@ast
Growth hormone deficiency and vascular risk.
@en
Growth hormone deficiency and vascular risk.
@nl
P2093
P2860
P1476
Growth hormone deficiency and vascular risk.
@en
P2093
John M C Connell
John R Petrie
Roland W McCallum
P2860
P356
10.1046/J.1365-2265.2002.01559.X
P577
2002-07-01T00:00:00Z